1. Home
  2. PLSE vs UPBD Comparison

PLSE vs UPBD Comparison

Compare PLSE & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • UPBD
  • Stock Information
  • Founded
  • PLSE 2014
  • UPBD 1986
  • Country
  • PLSE United States
  • UPBD United States
  • Employees
  • PLSE N/A
  • UPBD N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • UPBD Diversified Commercial Services
  • Sector
  • PLSE Health Care
  • UPBD Consumer Discretionary
  • Exchange
  • PLSE Nasdaq
  • UPBD Nasdaq
  • Market Cap
  • PLSE 1.3B
  • UPBD 1.2B
  • IPO Year
  • PLSE 2016
  • UPBD 1995
  • Fundamental
  • Price
  • PLSE $16.84
  • UPBD $23.73
  • Analyst Decision
  • PLSE
  • UPBD Buy
  • Analyst Count
  • PLSE 0
  • UPBD 5
  • Target Price
  • PLSE N/A
  • UPBD $36.60
  • AVG Volume (30 Days)
  • PLSE 163.1K
  • UPBD 562.5K
  • Earning Date
  • PLSE 05-08-2025
  • UPBD 05-01-2025
  • Dividend Yield
  • PLSE N/A
  • UPBD 6.47%
  • EPS Growth
  • PLSE N/A
  • UPBD N/A
  • EPS
  • PLSE N/A
  • UPBD 2.13
  • Revenue
  • PLSE N/A
  • UPBD $4,400,960,000.00
  • Revenue This Year
  • PLSE N/A
  • UPBD $8.37
  • Revenue Next Year
  • PLSE N/A
  • UPBD $6.79
  • P/E Ratio
  • PLSE N/A
  • UPBD $11.35
  • Revenue Growth
  • PLSE N/A
  • UPBD 8.07
  • 52 Week Low
  • PLSE $6.66
  • UPBD $19.68
  • 52 Week High
  • PLSE $25.00
  • UPBD $38.72
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 49.42
  • UPBD 58.05
  • Support Level
  • PLSE $15.92
  • UPBD $22.99
  • Resistance Level
  • PLSE $17.54
  • UPBD $24.60
  • Average True Range (ATR)
  • PLSE 0.90
  • UPBD 0.90
  • MACD
  • PLSE -0.09
  • UPBD 0.49
  • Stochastic Oscillator
  • PLSE 29.65
  • UPBD 82.90

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

Share on Social Networks: